159 related articles for article (PubMed ID: 2860239)
21. M2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal.
Chou WB; Zeng YM; Duan SM; Zhou WH; Gu J; Yang GD
Acta Pharmacol Sin; 2002 Aug; 23(8):691-7. PubMed ID: 12147190
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of stress on gene transcription factors in catecholaminergic systems.
Sabban EL; Hebert MA; Liu X; Nankova B; Serova L
Ann N Y Acad Sci; 2004 Dec; 1032():130-40. PubMed ID: 15677400
[TBL] [Abstract][Full Text] [Related]
23. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
24. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse.
Reis DJ; Ross RA; Joh TH
Brain Res; 1977 Nov; 136(3):465-74. PubMed ID: 21723
[No Abstract] [Full Text] [Related]
25. Nicotine infusion modulates immobilization stress-triggered induction of gene expression of rat catecholamine biosynthetic enzymes.
Serova L; Danailov E; Chamas F; Sabban EL
J Pharmacol Exp Ther; 1999 Nov; 291(2):884-92. PubMed ID: 10525113
[TBL] [Abstract][Full Text] [Related]
26. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
27. Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat hearts.
Rabadán JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1997 Jan; 280(1):32-7. PubMed ID: 8996178
[TBL] [Abstract][Full Text] [Related]
28. Effects of morphine on the rat adrenal medulla.
Anderson TR; Slotkin TA
Biochem Pharmacol; 1975 Mar; 24(6):671-9. PubMed ID: 235930
[No Abstract] [Full Text] [Related]
29. Influence of morphine tolerance and withdrawal on intestinal salt and water transport in the rat in vivo and in vitro.
Warhurst G; Smith GS; Higgs N; Tonge A; Turnberg LA
Gastroenterology; 1984 Nov; 87(5):1035-41. PubMed ID: 6541171
[TBL] [Abstract][Full Text] [Related]
30. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
Jones KL; Barr GA
Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
[TBL] [Abstract][Full Text] [Related]
31. Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Marín MT; Milanés MV
J Neurochem; 2005 Dec; 95(5):1249-58. PubMed ID: 16190878
[TBL] [Abstract][Full Text] [Related]
32. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
33. Adrenal catecholamine secretory responses in young and adult dogs.
Sakuma N; Nagasaka N; Morita K; Dohi T; Tsujimoto A
Arch Int Pharmacodyn Ther; 1993; 322():80-90. PubMed ID: 8105763
[TBL] [Abstract][Full Text] [Related]
34. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
[TBL] [Abstract][Full Text] [Related]
35. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine-synthesizing enzymes and chromogranin proteins in drug-induced proliferative lesions of the rat adrenal medulla.
Tischler AS; Ruzicka LA; Van Pelt CS; Sandusky GE
Lab Invest; 1990 Jul; 63(1):44-51. PubMed ID: 1695697
[TBL] [Abstract][Full Text] [Related]
37. Estrogen modifies stress response of catecholamine biosynthetic enzyme genes and cardiovascular system in ovariectomized female rats.
Serova LI; Maharjan S; Sabban EL
Neuroscience; 2005; 132(2):249-59. PubMed ID: 15802180
[TBL] [Abstract][Full Text] [Related]
38. Maturation of the adrenal medulla--IV. Effects of morphine.
Anderson TR; Slotkin TA
Biochem Pharmacol; 1975 Aug; 24(16):1469-74. PubMed ID: 7
[No Abstract] [Full Text] [Related]
39. Tyrosine hydroxylase activity in adrenal medulla of rats following acute and chronic administration of ethanol.
Masserano JM; Takimoto GS; Weiner N
Proc West Pharmacol Soc; 1979; 22():155-8. PubMed ID: 42080
[No Abstract] [Full Text] [Related]
40. p-Chlorophenylalanine-induced enhancement of the effects of morphine on the adrenal medulla.
Anderson TR; Slotkin TA
Biochem Pharmacol; 1976 Jul; 25(13):1547-8. PubMed ID: 8045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
